NOXAFIL
- Product NDC
- 0085-1328
- 11-digit product format
- 000851328
- Labeler code
- 0085
- Product ID
- 0085-1328_56740f7d-3b29-4786-b5c7-eea6c0f14400
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- posaconazole
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Merck Sharp & Dohme LLC
- Application
- NDA022003
- Marketing category
- NDA
- Marketing start
- 2006-09-15
- Substance
- POSACONAZOLE
- Active strength
- 40 mg/mL
- Pharmacologic classes
- Azole Antifungal [EPC], Azoles [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NOXAFIL
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POSACONAZOLE | 40 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 6TK1G07BHZ |
| Rxcui | 665019, 665022, 1482908, 1482912, 1492043, 1492047, 2558603, 2558607 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dc1eab98-5691-4d9a-82e4-7e2823a44fa6 | Product name | 9 | 20251124 |
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| cb89b86a-369e-4204-8910-ae797c503af3 | Product name | 1 | 20230706 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| d4880ace-a516-8c47-8dfd-73a4ba5887d7 | Product name | 2 | 20180830 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0085-1328-01 | NOXAFIL | 105 mL in 1 BOTTLE, GLASS | SUSPENSION | 105 | 56 | |
| 0085-1328-01 | NOXAFIL | 1 in 1 CARTON | SUSPENSION | 1 | 56 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0085-1328-01 | ML - Milliliter | 0085-1328 | 5f2a78f4-76ea-47c2-8ef1-a6f5df8cd312 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0085-1328 | NOXAFIL (POSACONAZOLE) SUSPENSION NOXAFIL (POSACONAZOLE) TABLET, COATED NOXAFIL (POSACONAZOLE) SOLUTION NOXAFIL (POSACONAZOLE) POWDER, FOR SUSPENSION [MERCK SHARP & DOHME LLC] | 52 | Current NDC, Legacy NDC, 2 package rows | 20241109_b073b082-7b57-4423-8c06-4fd4263d6f84.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1482912 | Noxafil 100 MG Delayed Release Oral Tablet | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 665022 | NOXAFIL 200 MG in 5 mL Oral Suspension | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1492047 | NOXAFIL 300 MG in 16.7 ML Injection | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 2558607 | Noxafil PowderMix 300 MG Powder for Oral Suspension | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1482908 | posaconazole 100 MG Delayed Release Oral Tablet | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 665019 | posaconazole 200 MG in 5 mL Oral Suspension | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1492043 | posaconazole 300 MG in 16.7 ML Injection | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 2558603 | posaconazole 300 MG Powder for Oral Suspension | PSN | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1492047 | 16.7 ML posaconazole 18 MG/ML Injection [Noxafil] | SBD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1482912 | posaconazole 100 MG Delayed Release Oral Tablet [Noxafil] | SBD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 2558607 | posaconazole 300 MG Powder for Oral Suspension [Noxafil] | SBD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 665022 | posaconazole 40 MG/ML Oral Suspension [Noxafil] | SBD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1492043 | 16.7 ML posaconazole 18 MG/ML Injection | SCD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1482908 | posaconazole 100 MG Delayed Release Oral Tablet | SCD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 2558603 | posaconazole 300 MG Powder for Oral Suspension | SCD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 665019 | posaconazole 40 MG/ML Oral Suspension | SCD | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1482912 | Noxafil 100 MG Delayed Release Oral Tablet | SY | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 665022 | Noxafil 200 MG per 5 ML Oral Suspension | SY | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1492047 | Noxafil 300 MG per 16.7 ML Injection | SY | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 2558607 | Noxafil 300 MG Powder for Oral Suspension | SY | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 665022 | Noxafil 40 MG/ML Oral Suspension | SY | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 665019 | posaconazole 200 MG per 5 ML Oral Suspension | SY | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
| 1492043 | posaconazole 300 MG per 16.7 ML Injection | SY | b073b082-7b57-4423-8c06-4fd4263d6f84 | 56 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0085-1328-01 | 00085132801 | 1 BOTTLE, GLASS in 1 CARTON (0085-1328-01) / 105 mL in 1 BOTTLE, GLASS | 2006-09-15 | 0000-00-00 | No | No | Current |